Literature DB >> 24478109

Operative outcomes of adult living donor liver transplantation and deceased donor liver transplantation: a systematic review and meta-analysis.

Ping Wan1, Xin Yu, Qiang Xia.   

Abstract

Living donor liver transplantation (LDLT) has emerged as an alternative to deceased donor liver transplantation (DDLT) because of the increasing number of patients waiting for liver transplantation (LT). However, whether it can achieve operative outcomes similar to those achieved with DDLT for adult patients remains controversial. We conducted this meta-analysis to compare the operative outcomes of LDLT and DDLT recipients. A literature search was performed to identify clinical controlled studies comparing LDLT and DDLT that were published before October 2013. Four perioperative outcomes [duration of the recipient operation (DRO), red blood cell (RBC) transfusion requirement, length of the hospital stay, and cold ischemia time (CIT)] and 5 postoperative complication outcomes (biliary complications, vascular complications, intra-abdominal bleeding, perioperative death, and retransplantation) were the main outcomes assessed. Nineteen studies with a total of 5450 patients were included in the meta-analysis. In comparison with DDLT, LDLT was associated with a significantly longer DRO and a shorter CIT. We found that biliary complications [odds ratio (OR) = 3.08, 95% confidence interval (CI) = 1.97-4.81, P < 0.001], vascular complications (OR = 2.16, 95% CI = 1.32-3.54, P = 0.002), and retransplantation (OR = 1.76, 95% CI = 1.09-2.83, P = 0.02) occurred more frequently for LDLT recipients, and the subgroup analysis indicated that the biliary complication rate decreased dramatically with greater LDLT experience. No significant difference was observed in RBC transfusion requirements, the lengths of hospital stays, intra-abdominal bleeding rates, or perioperative mortality between LDLT and DDLT recipients. In conclusion, LDLT is associated with a higher rate of surgical complications after transplantation. A reduction of postoperative complication rates can be achieved as centers gain greater experience with LDLT. However, LDLT is still an excellent alternative to DDLT because it facilitates access to LT.
© 2014 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2014        PMID: 24478109     DOI: 10.1002/lt.23836

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  30 in total

Review 1.  Living donor liver transplantation: eliminating the wait for death in end-stage liver disease?

Authors:  Robert A Fisher
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-02-15       Impact factor: 46.802

Review 2.  [Living liver donor: indications and technical aspects].

Authors:  S Nadalin; I Capobianco; I Königsrainer; B Harder; A Königsrainer
Journal:  Chirurg       Date:  2015-06       Impact factor: 0.955

Review 3.  A review of life quality in living donors after liver transplantation.

Authors:  Dong-Wei Xu; Xi-Dai Long; Qiang Xia
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 4.  Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review.

Authors:  Dong-Wei Xu; Ping Wan; Qiang Xia
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

5.  Acceptance of living liver donation among medical students: A multicenter stratified study from Spain.

Authors:  Antonio Ríos; Ana Isabel López-Navas; Ana Isabel López-López; Francisco Javier Gómez; Jorge Iriarte; Rafael Herruzo; Gerardo Blanco; Francisco Javier Llorca; Angel Asunsolo; Pilar Sánchez-Gallegos; Pedro Ramón Gutiérrez; Ana Fernández; María Teresa de Jesús; Laura Martínez-Alarcón; Alberto Lana; Lorena Fuentes; Juan Ramón Hernández; Julio Virseda; José Yelamos; José Antonio Bondía; Antonio Miguel Hernández; Marco Antonio Ayala; Pablo Ramírez; Pascual Parrilla
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

6.  Comparing 10-yr renal outcomes in deceased donor and living donor liver transplants.

Authors:  Shaifali Sandal; Anthony Almudevar; Sandesh Parajuli; Anirban Bose
Journal:  Clin Transplant       Date:  2015-11-05       Impact factor: 2.863

Review 7.  Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols.

Authors:  Danijel Galun; Dragan Basaric; Marinko Zuvela; Predrag Bulajic; Aleksandar Bogdanovic; Nemanja Bidzic; Miroslav Milicevic
Journal:  World J Hepatol       Date:  2015-09-18

8.  Arterial and biliary complications after living donor liver transplantation: a single-center retrospective study and literature review.

Authors:  Shigehito Miyagi; Yuta Kakizaki; Kenji Shimizu; Koji Miyazawa; Wataru Nakanishi; Yasuyuki Hara; Kazuaki Tokodai; Chikashi Nakanishi; Takashi Kamei; Noriaki Ohuchi; Susumu Satomi
Journal:  Surg Today       Date:  2017-04-24       Impact factor: 2.549

9.  Defining long-term outcomes with living donor liver transplantation in North America.

Authors:  Kim M Olthoff; Abigail R Smith; Michael Abecassis; Talia Baker; Jean C Emond; Carl L Berg; Charlotte A Beil; James R Burton; Robert A Fisher; Chris E Freise; Brenda W Gillespie; David R Grant; Abhinav Humar; Igal Kam; Robert M Merion; Elizabeth A Pomfret; Benjamin Samstein; Abraham Shaked
Journal:  Ann Surg       Date:  2015-09       Impact factor: 12.969

10.  Liver transplantation for biliary atresia: A single-center study from mainland China.

Authors:  Qi-Gen Li; Ping Wan; Jian-Jun Zhang; Qi-Min Chen; Xiao-Song Chen; Long-Zhi Han; Qiang Xia
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.